Neuroscience is complex, getting valuable insights shouldn't be

Our AI technology synthesizes patients’ composite history into powerful mathematical models that can be used to identify hidden patterns and predict health outcomes.

A burden that’s costing billions

Neurological conditions are the leading cause of disability and the second leading cause of death worldwide¹. This extraordinary burden, coupled with the lack of cures, results in a $765 billion spend in the US annually².

Successful strategies for the prevention and management of neurological disorders are needed to improve early diagnosis, rehabilitation, and treatment outcomes.

Sources:

Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P, Brainin M, Murray C. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020 Mar;19(3):255-265. doi: 10.1016/S1474-4422(19)30411-9. Epub 2019 Dec 5. PMID: 31813850; PMCID: PMC9945815.
GBD 2017 US Neurological Disorders Collaborators. Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study. JAMA Neurol. 2021;78(2):165–176. doi:10.1001/jamaneurol.2020.4152

Improve R&D and advance personalized medicine with OM1's RWD and AI for neuroscience

OM1 is reimagining real-world evidence with the development of large, electronically connected networks of clinicians in key specialty areas.

OM1 Neurology Datasets

Coming Soon!

Myasthenia gravis
Migraine

OM1 Neuroscience Network

The OM1 Neuroscience Network collects, processes, and deterministically links millions of real-world data points from specialist and primary care practices to a variety of continuously updated sources.

The data are available to license for in-house use or for custom research and analytics projects in partnership with OM1’s world class clinical experts, biostatistics, epidemiology, data science, and AI teams.

Specialized prospective data capture is also available for hard-to-get patient-reported outcomes or specialized clinical assessments that are not routinely captured in clinical practice.

OM1 Neurology Network

✔ 1 million+ patients

✔ 3,100 neurologists

✔ 2,500 specialty practices

✔ Longitudinal since 2015

✔ All 50 US States

✔ PROs including MMSE, MOCA, EDSS

✔ Additional data collection can be added

Distribution of Patients in the OM1 Neurology Network

Harness the largest neuroscience network in the U.S. with leading AI and data science techniques

To enrich the data, we extract information from structured and unstructured clinician notes, with artificial intelligence (AI) and language modeling capabilities. Data points include:

Key symptoms
Disease severity
Treatments
Longitudinal outcomes
Clinical response